Cargando…
A personalized stepwise dynamic predictive algorithm of the time to first treatment in chronic lymphocytic leukemia
Personalized prediction is ideal in chronic lymphocytic leukemia (CLL). Although refined models have been developed, stratifying patients in risk groups, it is required to accommodate time-dependent information of patients, to address the clinical heterogeneity observed within these groups. In this...
Autores principales: | Moysiadis, Theodoros, Koparanis, Dimitris, Liapis, Konstantinos, Ganopoulou, Maria, Vrachiolias, George, Katakis, Ioannis, Moyssiadis, Chronis, Vizirianakis, Ioannis S., Angelis, Lefteris, Fokianos, Konstantinos, Kotsianidis, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470317/ https://www.ncbi.nlm.nih.gov/pubmed/37664638 http://dx.doi.org/10.1016/j.isci.2023.107591 |
Ejemplares similares
-
Single Nucleotide Polymorphisms’ Causal Structure Robustness within Coronary Artery Disease Patients
por: Ganopoulou, Maria, et al.
Publicado: (2023) -
Common cardiovascular biomarkers can independently predict outcome of patients with Myelodysplastic syndromes
por: Mitroulis, Ioannis, et al.
Publicado: (2023) -
Could Causal Discovery in Proteogenomics Assist in Understanding Gene–Protein Relations? A Perennial Fruit Tree Case Study Using Sweet Cherry as a Model
por: Ganopoulou, Maria, et al.
Publicado: (2021) -
Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?
por: Liapis, Konstantinos, et al.
Publicado: (2021) -
P706: RESISTANCE TO HYPOMETHYLATING AGENTS (HMA) IN HIGH-RISKMYELODYSPLASTIC SYNDROME (HR-MDS): THE ROLE OF THE ADENOSINEDEAMINASE ACTING ON RNA 1 (ADAR1) ENZYME
por: Dimitriou, Despoina, et al.
Publicado: (2023)